Zhejiang Ausun Pharmaceutical Co., Ltd.
SSE:603229.SS
9.45 (CNY) • At close June 12, 2025
Overview | Financials
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operationele Activiteiten: | |||||||||||||
| Nettowinst
| 206.791 | 253.902 | 235.376 | 145.93 | 86.836 | 56.387 | 43.864 | 53.012 | 57.328 | 60.865 | 21.501 | 15.553 | 2.294 |
| Afschrijvingen & Amortisatie
| 63.658 | 40.593 | 34.478 | 30.024 | 25.426 | 22.732 | 20.701 | 17.874 | 15.128 | 11.472 | 10.865 | 7.969 | 3.487 |
| Uitgestelde Inkomstenbelasting
| 0 | -3.571 | 10.118 | 0.245 | -1.318 | -0.935 | 0.147 | -1.195 | 0.127 | -0.658 | 0 | 0 | 0 |
| Aandelen Gebaseerde Vergoedingen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23.8 | 0 | 0 |
| Verandering in Werkkapitaal
| -77.342 | -70.966 | -114.961 | -7.286 | -5.762 | 4.461 | -39.206 | -43.784 | 21.13 | -29.181 | -42.859 | -13.198 | -9.867 |
| Vorderingen
| -23.027 | 34.451 | -69.41 | -101.893 | 24.441 | -0.552 | 8.833 | -19.263 | 46.947 | -78.517 | -46.429 | 4.723 | -12.372 |
| Voorraden
| -45.591 | -79.38 | -153.137 | -56.986 | -6.513 | -66.717 | -5.457 | -69.599 | -15.533 | 2.06 | -16.732 | -26.617 | -13.994 |
| Crediteuren
| 0 | -26.037 | 97.469 | 151.347 | -22.371 | 72.666 | -42.729 | 46.274 | -10.411 | 47.935 | 0 | 0 | 0 |
| Overig Werkkapitaal
| -8.724 | 0 | 10.118 | 0.245 | -1.318 | -0.935 | -33.749 | 25.816 | 36.663 | -31.241 | -26.127 | 13.419 | 4.127 |
| Overige Niet-Contante Posten
| -15.181 | 1.891 | -34.326 | 5.233 | 31.97 | 4.15 | -13.856 | 19.683 | -0.379 | 10.471 | 31.944 | 5.406 | 2.948 |
| Kasstroom uit Operationele Activiteiten
| 177.926 | 221.848 | 120.567 | 173.901 | 138.47 | 87.73 | 11.504 | 46.785 | 93.208 | 53.626 | 21.45 | 15.73 | -1.138 |
| Investeringsactiviteiten: | |||||||||||||
| Investeringen in Materiële Vaste Activa
| -111.302 | -163.47 | -271.914 | -310.853 | -92.955 | -49.625 | -55.054 | -54.365 | -42.788 | -42.803 | -23.082 | -36.71 | -37.539 |
| Netto Overnames
| 0 | 0.191 | 0.187 | 0.211 | 0.012 | 0.038 | 0.072 | 0.02 | 0 | 0 | 0 | 0 | 0 |
| Aankoop van Beleggingen
| -2.25 | -18 | -17.5 | -10 | -13.079 | -150 | -225 | -60 | 0 | 0 | 0 | 0 | 0 |
| Verkoop/verval van Beleggingen
| 0 | 0 | 619.485 | 516.76 | 115.364 | 195.833 | 0.686 | 0.324 | 0 | 0 | 0 | 0 | 0 |
| Overige Investeringsactiviteiten
| -6.417 | 5.808 | -508.105 | -628.422 | -114.784 | 1.544 | 17.69 | -57.47 | 1.838 | 1.12 | 2.13 | 0.073 | 6.014 |
| Kasstroom uit Investeringsactiviteiten
| -119.969 | -175.47 | -177.847 | -432.304 | -105.441 | -2.211 | -36.677 | -111.511 | -40.949 | -41.683 | -20.952 | -36.637 | -31.525 |
| Financieringsactiviteiten: | |||||||||||||
| Schuldaflossingen
| -29.9 | 58.3 | 131.9 | 68.8 | -3.9 | -27.1 | 72 | -60.6 | 5.72 | -20.76 | 5.14 | 21 | 30.5 |
| Uitgifte van Gewone Aandelen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | -18.906 | 0 | 0 | 0 | 0 | 0 |
| Terugkoop van Gewone Aandelen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Uitgekeerde Dividenden
| -84.215 | -57.449 | -29.279 | -17.94 | -12 | -8.8 | -14.17 | -2.967 | -5.508 | -4.226 | -5.042 | -4.398 | -2.462 |
| Overige Financieringsactiviteiten
| 5.895 | 469.075 | -7.704 | -11.795 | 406.097 | -0 | 0 | 284.9 | -0 | 49 | -0 | 7 | 0 |
| Kasstroom uit Financieringsactiviteiten
| -108.22 | 469.925 | 94.917 | 37.035 | 390.197 | -38.452 | 57.83 | 202.427 | 0.212 | 24.014 | 0.098 | 23.602 | 28.038 |
| Overige Informatie: | |||||||||||||
| Effect van Wisselkoersveranderingen op Kas
| 10.843 | 7.952 | 37.181 | -10.633 | -19.923 | 3.595 | 13.447 | -10.384 | -0 | 0 | -0 | -0 | 0 |
| Netto Kasstroomverandering
| -39.42 | 524.255 | 74.818 | -232.002 | 403.303 | 50.661 | 46.104 | 127.316 | 52.47 | 35.957 | 0.597 | 2.695 | -4.626 |
| Kaspositie aan het Einde van de Periode
| 1,048.581 | 1,088.002 | 563.747 | 488.928 | 720.93 | 317.627 | 266.965 | 220.862 | 93.546 | 41.075 | 5.118 | 4.522 | 1.826 |